VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NSP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NSPInsperity, Inc.
$42.60$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNSPFinancials

Insperity, Inc. (NSP) Financials

30Y historyFree accessUpdated daily

Revenue growth has slowed to 1.7% as of 2026Q1, while gross margins remain highly sensitive to benefit costs, fluctuating between a 19.1% peak and a 10.3% trough.

NSP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue6.84B6.81B6.58B6.49B5.94B4.97B4.29B4.31B3.83B3.3B2.94B2.6B2.36B2.26B2.16B1.98B1.72B1.65B1.72B1.57B1.39B1.17B969.53M891.72M849.02M4.37B3.71B2.26B1.68B1.21B899.6M
Revenue Growth %3.04%3.51%1.46%9.21%19.42%16%-0.64%12.7%16.01%12.2%12.97%10.43%4.51%4.51%9.24%14.91%4.03%-4.14%9.84%12.99%18.8%20.64%8.73%5.03%-80.59%17.92%64.04%34.32%38.69%34.9%25.61%
Cost of Goods Sold5.96B5.91B5.53B5.45B4.93B4.15B3.48B3.58B3.15B2.73B2.45B2.17B1.95B1.86B1.78B1.62B1.42B1.37B1.38B1.26B1.11B933.86M771.83M693.75M682.63M4.21B3.57B2.17B1.61B1.16B861.6M
COGS % of Revenue-86.79%84.01%84.01%82.97%83.51%81.18%83.01%82.19%82.65%83.29%83.18%82.87%82.57%82.29%82.2%82.64%82.58%80.07%80.51%79.65%79.84%79.61%77.8%80.4%96.23%96.26%96.04%95.92%95.78%95.78%
Gross Profit881M900M1.05B1.04B1.01B820.1M806.85M732.93M681.91M572.73M491.61M437.87M403.81M393.25M382.22M351.77M298.54M287.97M343.74M305.92M282.73M235.76M197.69M197.97M166.39M165.01M138.53M89.5M68.6M51.2M38M
Gross Margin %12.87%13.21%15.99%15.99%17.03%16.49%18.82%16.99%17.81%17.35%16.71%16.82%17.13%17.43%17.71%17.8%17.36%17.42%19.93%19.49%20.35%20.16%20.39%22.2%19.6%3.77%3.74%3.96%4.08%4.22%4.22%
Gross Profit Growth %--14.45%1.45%2.55%23.31%1.64%10.09%7.48%19.06%16.5%12.27%8.44%2.68%2.89%8.65%17.83%3.67%-16.23%12.36%8.2%19.92%19.25%-0.14%18.98%0.83%19.12%54.79%30.47%33.98%34.74%30.58%
Operating Expenses897M910M935M818M760.99M646.77M612.16M546.3M502.87M442.79M385.3M361.69M352.64M333.69M310.54M294.46M261.48M260.93M278.76M243.71M221.16M191.99M175.56M173.69M168.24M146.48M116.3M78.9M57.4M42M31.4M
OpEx % of Revenue-13.36%14.21%12.61%12.81%13.01%14.28%12.66%13.13%13.42%13.1%13.89%14.96%14.79%14.38%14.9%15.2%15.78%16.17%15.52%15.92%16.41%18.11%19.48%19.82%3.35%3.14%3.49%3.41%3.46%3.49%
Selling, General & Admin530M241M891M728M720.33M573.3M580.98M517.58M480.03M424.61M368.66M343.12M331.26M312.62M292.29M279.24M246.57M244.34M263.19M227.55M205.73M176.82M158.05M152.93M146.6M129.59M104.3M70.4M53.7M39.8M29.9M
SG&A % of Revenue-3.54%13.54%11.22%12.13%11.53%13.55%12%12.54%12.87%12.53%13.18%14.05%13.86%13.54%14.13%14.34%14.78%15.26%14.49%14.81%15.12%16.3%17.15%17.27%2.96%2.81%3.11%3.19%3.28%3.32%
Research & Development0013M013.2M10.9M8.7M7.8M6M4.1M3M3.3M4.1M3.6M2.8M0000000000000000
R&D % of Revenue--0.2%-0.22%0.22%0.2%0.18%0.16%0.12%0.1%0.13%0.17%0.16%0.13%----------------
Other Operating Expenses4M669M31M90M27.46M62.57M22.49M20.92M22.84M18.18M16.64M-113K47K-2.65M187K15.22M14.91M16.59M15.57M16.16M15.44M15.17M17.51M20.76M21.64M16.88M12M8.5M3.7M2.2M1.5M
Operating Income-16M-10M117M219M250.24M173.33M194.69M186.63M179.04M129.94M106.31M65.7M47.47M56.22M67.49M57.31M37.06M27.03M64.98M62.21M61.56M43.77M22.13M24.27M-1.85M18.54M22.23M10.6M11.2M9.2M6.6M
Operating Margin %-0.23%-0.15%1.78%3.38%4.21%3.49%4.54%4.33%4.68%3.94%3.61%2.52%2.01%2.49%3.13%2.9%2.15%1.64%3.77%3.96%4.43%3.74%2.28%2.72%-0.22%0.42%0.6%0.47%0.67%0.76%0.73%
Operating Income Growth %--108.55%-46.58%-12.48%44.37%-10.97%4.32%4.24%37.78%22.23%61.81%38.39%-15.56%-16.7%17.76%54.65%37.09%-58.4%4.45%1.05%40.67%97.76%-8.83%1412.11%-109.98%-16.62%109.75%-5.36%21.74%39.39%200%
EBITDA29M35M161M262M290.9M211.88M225.88M215.36M201.88M148.12M122.95M84.26M68.86M77.26M85.68M72.53M52.01M43.59M80.52M78.76M77.1M59.25M39.9M46.46M20.01M35.61M34.2M18.2M15.4M11.9M8.3M
EBITDA Margin %0.42%0.51%2.45%4.04%4.9%4.26%5.27%4.99%5.27%4.49%4.18%3.24%2.92%3.42%3.97%3.67%3.02%2.64%4.67%5.02%5.55%5.07%4.12%5.21%2.36%0.81%0.92%0.81%0.92%0.98%0.92%
EBITDA Growth %-76.03%-78.26%-38.55%-9.93%37.3%-6.2%4.89%6.68%36.29%20.47%45.91%22.37%-10.87%-9.83%18.12%39.46%19.31%-45.86%2.24%2.16%30.12%48.49%-14.12%132.21%-43.82%4.13%87.93%18.18%29.41%43.37%151.52%
D&A (Non-Cash Add-back)45M45M44M43M40.66M38.55M31.19M28.72M22.84M18.18M16.64M18.57M21.39M21.03M18.18M15.22M14.95M16.56M15.54M16.55M15.53M15.48M17.77M22.18M21.86M17.07M11.97M7.6M4.2M2.7M1.7M
EBIT11M20M154M252M259.63M175.78M197.29M197.29M187.03M133.35M107.57M66.08M48M59.56M71.69M57.31M37.06M27.03M64.98M62.21M61.56M43.77M22.13M24.27M67K18.54M22.23M12M11.3M9.2M6.6M
Net Interest Income3M6M9M6M-4.81M-5.01M-5.42M3.01M3.32M200K-1.13M-80K153K158K609K969K961K1.62M7.04M000000000000
Interest Income27M30M37M33M9.39M2.45M2.6M10.66M7.99M3.41M1.27M379K153K158K609K969K961K1.62M7.04M0000004.13M00000
Interest Expense24M24M28M27M14.21M7.46M8.02M7.65M4.67M3.21M2.4M459K0000000000000000000
Other Income/Expense3M6M9M6M-4.81M-5.01M-5.42M3.01M3.32M200K-1.13M-80K153K-2.49M796K-6.54M961K1.62M7.04M11.22M10.52M3.98M8.61M196K-3.66M848K4.38M3.7M3.4M2.7M-1.8M
Pretax Income-13M-4M126M225M245.43M168.32M189.27M189.64M182.36M130.14M105.18M65.62M47.63M53.73M68.29M50.77M38.02M28.65M72.02M73.44M72.08M47.75M30.74M24.47M-3.6M19.39M26.61M14.2M14.6M11.9M4.8M
Pretax Margin %-0.19%-0.06%1.91%3.47%4.13%3.38%4.42%4.4%4.76%3.94%3.58%2.52%2.02%2.38%3.16%2.57%2.21%1.73%4.18%4.68%5.19%4.08%3.17%2.74%-0.42%0.44%0.72%0.63%0.87%0.98%0.53%
Income Tax12M3M35M54M66.08M44.24M51.03M38.54M46.95M45.74M39.19M26.23M19.62M21.7M27.89M20.3M15.58M12.07M26.24M25.95M25.58M17.76M11.53M9.48M484K9.03M9.71M4.9M5.5M4.5M2.2M
Effective Tax Rate %-92.31%-75%27.78%24%26.92%26.28%26.96%20.32%25.74%35.15%37.26%39.97%41.2%40.39%40.84%39.99%40.98%42.15%36.43%35.33%35.48%37.2%37.5%38.76%-13.46%46.58%36.5%34.51%37.67%37.82%45.83%
Net Income-25M-7M91M171M179.35M124.08M138.24M151.1M135.41M84.4M65.99M39.39M28M32.03M40.4M30.47M22.44M16.57M45.78M47.49M46.51M29.98M19.21M12.86M-4.08M10.36M16.9M9.4M9.1M7.4M2.6M
Net Margin %-0.37%-0.1%1.38%2.64%3.02%2.5%3.22%3.5%3.54%2.56%2.24%1.51%1.19%1.42%1.87%1.54%1.3%1%2.65%3.02%3.35%2.56%1.98%1.44%-0.48%0.24%0.46%0.42%0.54%0.61%0.29%
Net Income Growth %-139.68%-107.69%-46.78%-4.66%44.54%-10.24%-8.51%11.58%60.44%27.9%67.53%40.66%-12.57%-20.72%32.6%35.78%35.39%-63.8%-3.6%2.12%55.11%56.08%49.33%415.22%-139.4%-38.72%79.79%3.3%22.97%184.62%136.36%
Net Income (Continuing)-25M-7M91M171M179.35M124.08M138.24M151.1M135.41M84.4M65.99M39.39M28M32.03M40.4M30.47M22.44M16.57M45.78M47.49M46.51M29.98M19.21M14.98M-2.92M10.36M16.9M9.4M9.1M7.4M2.6M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)-0.66-0.182.394.474.643.183.543.743.272.011.550.790.530.630.780.580.430.330.900.870.820.560.360.24-0.080.180.290.170.160.130.06
EPS Growth %-139.91%-107.53%-46.53%-3.66%45.91%-10.17%-5.35%14.37%62.69%29.68%96.2%49.06%-15.87%-19.23%34.48%34.88%30.3%-63.33%3.45%6.1%46.43%55.56%50%420%-141.67%-37.93%70.59%6.25%23.08%116.67%140%
EPS (Basic)--0.182.394.534.713.223.573.763.292.021.550.790.530.630.790.580.430.330.910.890.850.580.370.24-0.080.190.310.170.160.140.06
Diluted Shares Outstanding37.7M38M38M38.34M38.62M38.95M38.82M40.35M41.47M41.24M41.74M48.62M49.42M49.74M50.13M50.99M50.74M49.83M51.15M54.59M56.71M53.54M53.36M54.74M54.41M57.54M58.28M55.29M58.71M55.85M44.42M
Basic Shares Outstanding37.7M38M38M37.83M38.12M38.47M38.5M40.19M41.22M41.03M41.61M48.62M49.42M49.7M50.01M50.81M50.51M49.54M50.47M53.36M55.04M51.69M51.92M53.6M54.41M54.51M53.41M55.29M57.78M52.86M44.42M
Dividend Payout Ratio--97.8%49.25%42.71%116.2%44.76%32.18%24.67%77.92%31.21%53.7%248.15%54.28%105.76%51.66%60.28%80.08%27.11%25.06%21.55%24.64%--------11.54%

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Rising medical benefit costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Facing Structural Headwinds

According to the latest quarterly filings, Insperity's revenue growth has decelerated to 1.7% as of 2026Q1, reflecting a cooling in worksite employee expansion that suggests the company's core PEO model is struggling to maintain its historical momentum within the current small and medium-sized business environment.

The deceleration in top-line growth appears to indicate that the company is facing increased competition or a broader slowdown in SMB hiring activity. Investors should monitor whether this trend represents a temporary cyclical trough or a more permanent loss of market share to automated HCM competitors.

Gross Margin Volatility Impairs Profitability

As reported in recent financial statements, Insperity's gross margin has exhibited significant volatility, swinging from a high of 19.1% in 2024Q1 to a low of 10.3% in 2025Q4, highlighting the company's sensitivity to unpredictable medical benefit costs and insurance-related pass-through expenses.

The thin and fluctuating gross margin profile suggests that Insperity lacks the pricing power to fully insulate its bottom line from healthcare inflation. This structural vulnerability warrants further investigation into the company's ability to adjust client service fees in alignment with rising actuarial risks.

Operating Leverage Constrained by Overhead

Based on the provided income statement data, Insperity's operating income has frequently dipped into negative territory, with a recent operating margin of -2.8% in 2025Q4, demonstrating that SG&A expenses are currently scaling faster than the company's ability to generate service fee revenue.

The inability to maintain positive operating leverage suggests that the company's high-touch service model may be becoming prohibitively expensive to support at current volume levels. Management appears to be struggling to achieve the necessary administrative efficiency to offset the inherent volatility of the PEO business model.

Earnings Quality Impacted by SBC

Analysis of the reported figures reveals that stock-based compensation, which reached $20 million in 2025Q2, continues to weigh on net income, complicating the assessment of true operational profitability during periods where the company is already reporting negative net margins.

The presence of significant stock-based compensation during quarters of net losses suggests that shareholders are bearing the cost of dilution without the benefit of bottom-line growth. This practice may obscure the underlying operational performance and warrants caution regarding the sustainability of current compensation structures.

Structural Risks to PEO Model

While the company maintains a high-touch service moat, the persistent negative net margin of -0.10% suggests that the current business model may be fundamentally misaligned with the rising cost of medical benefits and the competitive pressures of the modern HCM software landscape.

Short-sellers may focus on the company's inability to return to consistent profitability, viewing the current margin compression as a structural decline rather than a temporary mismatch. The reliance on gross revenue reporting may also be masking a deeper deterioration in the value proposition of the core PEO offering.

NSP — Frequently Asked Questions

Quick answers to the most common questions about buying NSP stock.

What was Insperity, Inc.'s (NSP) revenue in 2025?

For fiscal year 2025, Insperity, Inc. (NSP) reported total revenue of $6.81B. This represents a 657.2% increase compared to $899.6M in 1996.

Is Insperity, Inc. (NSP) profitable?

Insperity, Inc. (NSP) reported a net loss of $7.0M for the fiscal year ending 2025.

What is Insperity, Inc.'s operating profit margin?

Insperity, Inc. (NSP) reported an operating income of $-10.0M, resulting in an operating profit margin of -0.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Insperity, Inc.'s gross profit and gross margin?

Insperity, Inc. (NSP) generated $900.0M in gross profit for the year, representing a gross profit margin of 13.2%. This demonstrates the company's core pricing power and production efficiency.